Opdivo (nivolumab) - Ono Pharma, BMS
TT11 - Tessa Therap, UNC Lineberger Comprehensive Cancer Center, Baylor Scott & White Research Institute
https://www.globenewswire.com/news-release/2023/06/16/2689643/0/en/Tessa-Therapeutics-Announces-Positive-Results-from-CD30-CAR-T-Combination-Study-with-Nivolumab-in-2nd-line-Hodgkin-Lymphoma.html
 
Jun 16, 2023
 
Prev Next